DNA stable pentaploid H1 (ES) cells obtained from an octaploid cell induced from tetraploid cells polyploidized using demecolcine.
Pentaploid H1 (ES) cells (5H1 cells) were accidentally obtained through one-cell cloning of octaploid H1 (ES) cells (8H1 cells) that were established from tetraploid H1 (ES) cells (4H1 cells) polyploidized using demecolcine. The number of chromosomes of 5H1 cells was 100, unlike the 40 of diploid H1 (ES) cells (2H1 cells), 80 of 4H1, and 160 of 8H1 cells. The durations of G(1), S, and G(2)/M phases of 5H1 cells were 3, 7, and 6 h, respectively, almost the same as those of 2H1, 4H1, and 8H1 cells. The cell volume of 5H1 cells was half of that of 8H1 cells, suggesting that 5H1 cells were created through abnormal cell divisions of 8H1 cells. The morphology of growing 5H1 cells was a spherical cluster similar to that of 2H1 cells and differing from the flagstone-like shape of 4H1 and 8H1 cells. Pentaploid solid tumors were formed from 5H1 cells after interperitoneal injection into the mouse abdomen, and they contained endodermal, mesodermal, and ectodermal cells as well as undifferentiated cells, suggesting both that the DNA content of 5H1 cells was retained during tumor formation and that the 5H1 cells were pluripotent. The DNA content of 5H1 cells was stable in long-term culturing as 2H1 cells, meaning that 5H1 and 2H1 cells shared similarities in DNA structure. The excellent stability of the DNA content of 5H1 cells was explained using a hypothesis for the DNA structure of polyploid cells because the pairing of homologous chromosomes in 5H1 cells is spatially forbidden.
Fujikawa-Yamamoto
Kohzaburo
K
Division of Cell Medicine, Research Institute of Medical Science, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan. fujikawa@kanazawa-med.ac.jp
Luo
Xianwen
X
Miyagoshi
Minoru
M
Yamagishi
Hiroko
H
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics; D002455:Cell Division / Q000187:drug effects / Q000502:physiology*; D019070:Cell Lineage / Q000187:drug effects / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000187:drug effects*; D002478:Cells, Cultured; D043171:Chromosomal Instability / Q000235:genetics; D002869:Chromosome Aberrations / Q000187:drug effects*; D004247:DNA / Q000502:physiology*; D003703:Demecolcine / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D051379:Mice; D009369:Neoplasms / Q000235:genetics; D039904:Pluripotent Stem Cells / Q000502:physiology; D011123:Polyploidy; D033581:Stem Cell Transplantation / Q000379:methods
D000972:Antineoplastic Agents, Phytogenic; D004247:DNA; D003703:Demecolcine